PRELUDE CAPITAL MANAGEMENT, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$65,704
-53.2%
18,935
-37.2%
0.00%
-55.6%
Q2 2023$140,300
-1.4%
30,172
-2.0%
0.01%0.0%
Q1 2023$142,241
-8.6%
30,788
+59.9%
0.01%
+12.5%
Q4 2022$155,597
+2122.8%
19,257
+2651.0%
0.01%
Q3 2020$7,000
+133.3%
700
+75.0%
0.00%
Q2 2020$3,0000.0%400
+33.3%
0.00%
Q1 2020$3,0000.0%3000.0%0.00%
Q4 2019$3,000
-75.0%
300
-77.1%
0.00%
-100.0%
Q3 2019$12,000
+20.0%
1,312
+44.2%
0.00%
Q2 2019$10,0009100.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$33,918,00014.78%
Samsara BioCapital, LLC 1,675,579$31,149,0003.84%
First Light Asset Management, LLC 2,072,875$38,535,0002.31%
AJU IB Investment Co., Ltd. 175,000$3,253,0001.88%
FRAZIER MANAGEMENT LLC 1,001,421$18,616,0001.72%
Opaleye Management Inc. 496,900$9,237,0001.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$2,590,0000.68%
Parkman Healthcare Partners LLC 163,389$3,037,0000.66%
Eventide Asset Management 2,370,975$44,076,0000.59%
BVF INC/IL 826,825$15,371,0000.58%
View complete list of SUTRO BIOPHARMA INC shareholders